Literature DB >> 717392

Parasinusoidal location of megakaryocytes in marrow: a determinant of platelet release.

M A Lichtman, J K Chamberlain, W Simon, P A Santillo.   

Abstract

Megakaryocytopoiesis occurs in the hematopoietic (extravascular) compartment of marrow. Thus, platelets must traverse the wall of the vascular sinuses of marrow to enter the circulation. We have examined mouse and rat marrow, fixed by rapid immersion so as to maintain anatomical relationships as close to the natural state as possible. Quantitative transmission electron microscopy (TEM) of random transections of femurs established that megakaryocytes reside less than 1 mu from a marrow sinus wall with a probability unlikely to be the result of chance (P less than 0.001). An intimate relationship exists between the megakaryocyte periphery and the abluminal surface of the endothelial lining cell. At the time of platelet release megakaryocyte cytoplasm invaginates and penetrates the endothelial lining cell. The penetrating cytoplasm is detached and enters the marrow circulation. From their dimensions in comparison to circulating platelets, the released cytoplasm represents a packet of platelets that undergoes further fragmentation in the circulation. The parasinusoidal location of megakaryocytes and the process of sinus-wall penetration and platelet delivery was observed by TEM and scanning electron microscopy. These studies provided quantitative support for a specific anatomical arrangement of megakaryocytes in marrow. Moreover, the process of platelet release appears to be a physiological form of metastasis with invasion of vascular walls and vascular spread of cells, that are in this case amitotic.

Entities:  

Mesh:

Year:  1978        PMID: 717392     DOI: 10.1002/ajh.2830040402

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  27 in total

1.  Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept.

Authors:  D Zucker-Franklin; C S Philipp
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 2.  The end is just the beginning: megakaryocyte apoptosis and platelet release.

Authors:  J Li; D J Kuter
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

Review 3.  [Current models of thrombopoiesis].

Authors:  H Schulze
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 4.  In vivo platelet production from mature megakaryocytes: does platelet release occur via proplatelets?

Authors:  Goro Kosaki
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

Review 5.  The biogenesis of platelets from megakaryocyte proplatelets.

Authors:  Sunita R Patel; John H Hartwig; Joseph E Italiano
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

6.  Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation.

Authors:  Massimo Dominici; Valeria Rasini; Rita Bussolari; Xiaohua Chen; Ted J Hofmann; Carlotta Spano; Daniela Bernabei; Elena Veronesi; Filippo Bertoni; Paolo Paolucci; PierFranco Conte; Edwin M Horwitz
Journal:  Blood       Date:  2009-05-11       Impact factor: 22.113

Review 7.  Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. An overview.

Authors:  J Thiele; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 8.  Platelet production by megakaryocytes: protoplatelet theory justifies cytoplasmic fragmentation model.

Authors:  Goro Kosaki
Journal:  Int J Hematol       Date:  2008-08-28       Impact factor: 2.490

9.  The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation.

Authors:  Chaneun Nam; Adam J Case; Bruce S Hostager; M Sue O'Dorisio
Journal:  J Mol Neurosci       Date:  2008-07-29       Impact factor: 3.444

10.  Pulmonary megakaryocytes: "missing link" between cardiovascular and respiratory disease?

Authors:  G K Sharma; I C Talbot
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.